南京地区22家医院2006—2008年抗感染药物应用分析  

Utilization analysis of anti-infective agents in 22 hospitals of Nanjing area during 2006—2008

作　　者：张吉[1] 孟玲[1] 邹颖[1] 戴惠珍[2] 陶琳[3] 

机构地区：[1]南京医科大学第一附属医院,江苏南京210029 [2]江苏省医药情报研究所,江苏南京210004 [3]上海市食品药品监督管理局科技情报研究所,上海200233

出　　处：《中国新药与临床杂志》2010年第6期462-465,共4页Chinese Journal of New Drugs and Clinical Remedies

摘　　要：目的分析2006—2008年南京地区抗感染药物应用状况及趋势,为临床合理应用抗感染药及其科学管理提供依据。方法应用金额排序法和用药频度排序法,对南京地区22家医院2006—2008年临床使用的抗感染药物进行统计和分析。结果 2006—2008年抗感染药物用药总额增长迅速,年平均增长率达33.23%。其中β内酰胺类药物及喹诺酮类药物占市场份额的70%左右,位于DDDs排序前列的为左氧氟沙星和罗红霉素。结论 2006—2008年南京地区抗感染药物各品种使用情况比较稳定,但仍应加强对于β内酰胺类、喹诺酮类及大环内酯类等药物的管理,以提高药物疗效,减少药物耐药性。AIM To analyse the utilization and tendency of antibiotics in 22 hospitals of Nanjing area from 2006 to 2008 to provide basis for rational clinical use and scientific management of antibiotics.METHODS The use of antibiotics in 22 hospitals of Nanjing area during 2006—2008 were analyzed statistically in terms of drug consumption and DDDs.RESULTS The consumption sum increased during 2006—2008 and the average growth rate was 33.23%.The β-lactams antibiotics and quinolones occupied almost 70% of the market share,and levofloxacin and roxithromycin ranked the forefront in the orders of DDDs.CONCLUSION The consumption sum and DDDs ranking of antibiotics in Nanjing during 2006—2008 were stable and normal,but it is necessary to reinforce the control on the use of β-lactams antibiotics,quinolones,and macrolides,to improve drug effectivity and decrease drug resistance.

关 键 词：抗感染药 药物利用 经济学 药学 南京地区 

分 类 号：R978.1[医药卫生—药品] R956[医药卫生—药学]